Post Thumb

CRISPR mines bacterial genome for hidden pharmaceutical treasure

Share it

Using CRISPR-Cas9 gene-editing technology, researchers have now uncovered even more potential treasure hidden in silent genes.

A new study from researchers at the University of Illinois and colleagues at the Agency for Science, Technology and Research in Singapore used CRISPR technology to turn on unexpressed, or “Silent,” gene clusters in Streptomyces, a common class of bacteria that naturally produce many compounds that have already been used as antibiotics, anti-cancer agents and other drugs.

“The vast majority of biosynthetic gene clusters are not expressed under laboratory conditions, or are expressed at very low levels. That’s why we call them silent. There are a lot of new drugs and new knowledge waiting to be discovered from these silent gene clusters. They are truly hidden treasures.”

To mine for undiscovered genomic treasure, the researchers first used computational tools to identify silent biosynthetic gene clusters – small groups of genes involved in making chemical products.

Then they used CRISPR technology to insert a strong promoter sequence before each gene that they wanted to activate, prompting the cell to make the natural products that the genes clusters coded for.

“In the past, it was very difficult to turn on or off a specific gene in Streptomyces species. With CRISPR, now we can target almost any gene with high efficiency.”

Explore further: Unlocking the potential of bacterial gene clusters to discover new antibiotics.


Article originally posted at

Post Author: Carla Parsons

1 thought on “CRISPR mines bacterial genome for hidden pharmaceutical treasure

    Lindveld Stefanus Gary

    (October 29, 2017 - 7:52 am)


Leave a Reply

Your email address will not be published. Required fields are marked *